Liver Cirrhosis, Biliary: all 209 studies

Page 2 of 3. Open to participants first (45), then studies with results posted, then the rest; newest registration first within each.

• A Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid.CompletedNCT06383403Phase 3
• The Effectiveness of Combining Ursodeoxycholic Acid With Vitamin D in Treating Patients With Primary Biliary CholangitisCompletedNCT06309589Not applicable
• Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment.CompletedNCT06247735Phase 2
• Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary CholangitisActive, not recruitingNCT06174402Phase 2/3
• Study of [14C]CS0159 in China Healthy SubjectsCompletedNCT06098027Phase 1
• TruGraf Liver Gene Expression Serial TestTerminatedNCT06061341
• Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC)CompletedNCT06060665Phase 3
• CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis)Active, not recruitingNCT05896124Phase 2
• Evidence Based Mental Wellness Programming Online for Adults Across Chronic Physical ConditionsCompletedNCT05786482Not applicable
• Liver Cirrhosis Network Cohort StudyActive, not recruitingNCT05740358
• Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS0159 in Chinese Healthy SubjectsCompletedNCT05624294Phase 1
• Efficacy and Safety of Obeticholic Acid in the Treatment of Primary Biliary CholangitisCompletedNCT05450887Phase 3
• Mind-body Wellness Intervention in Primary Biliary Cholangitis (PBC)CompletedNCT05374200Not applicable
• A Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC PatientsWithdrawnNCT05293938
• Study to Evaluate the Safety and Efficacy of ASC42 Tablets in Subjects With Primary Biliary CholangitisCompletedNCT05190523Phase 2
• Saroglitazar Magnesium for Treatment of Primary Biliary CholangitisCompletedNCT05133336Phase 2/3
• Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary CholangitisCompletedNCT05104853Phase 1/2
• A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary CholangitisActive, not recruitingNCT05050136Phase 2
• Study of Obeticholic Acid（OCA） Combination With Ursodeoxycholic Acid (UDCA) in Patients With Primay Biliary Cirrhosis (PBC)Status unknownNCT04956328Phase 3
• A Randomised Clinical Trial Assessing the Efficacy and Safety of Mycophenolate Mofetil Versus Azathioprine for Induction of Remission in Treatment Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap SyndromeStatus unknownNCT04933292Phase 4
• PBC Induced Fatigue Treated With ThiamineStatus unknownNCT04893993Phase 4
• Online Wellness Intervention for Primary Biliary Cholangitis (PBC)CompletedNCT04791527Not applicable
• A Study to Assess Efficacy and Safety of Bezafibrate in Patients With Primary Biliary CholangitisStatus unknownNCT04751188Phase 3
• Physical Therapy for Liver CirrhosisCompletedNCT04629456Not applicable
• Ursodeoxycholic Acid Combined With Total Glucosides of Paeony in the Treatment of PBC With AIH Features 1Status unknownNCT04618575Phase 4
• Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features IIStatus unknownNCT04617561Phase 4
• Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation for Children Suffering From Biliary AtresiaCompletedNCT04522869Phase 1/2
• Advanced Endoscopy During COVID-19CompletedNCT04385147
• Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard TherapyStatus unknownNCT04376528Phase 4
• Antibiotics Treatment of Cholangitis Post-Kasai PortoenterostomyCompletedNCT04370145Phase 4
• Genomic Resources for Enhancing Available Therapies (GREAT1.0) StudySuspendedNCT04306939
• A Study of TQA3526 in the Treatment of Primary Biliary Cirrhosis (PBC)Status unknownNCT04278820Phase 2
• EXerCise Intervention in cholesTatic LivEr Disease: The EXCITED StudyTerminatedNCT04265235Not applicable
• Linerixibat Long-term Safety, and Tolerability StudyActive, not recruitingNCT04167358Phase 3
• Safety, Tolerability of OP-724 in Patients With Primary Biliary Cholangitis (Phase I)CompletedNCT04047160Phase 1
• Study to Evaluate the Safety and Efficacy of Oral CR845 (Difelikefalin) in Patients With Primary Biliary Cholangitis (PBC) and Moderate-to-Severe PruritusTerminatedNCT03995212Phase 2
• Combination Antiretroviral Therapy (cART) for PBCCompletedNCT03954327Phase 2
• Spontaneous Coronary Artery Dissection (SCAD) and AutoimmunityCompletedNCT03941184
• Repeatability and Reproducibility of Quantitative MRCPCompletedNCT03809559
• Repeatability and Reproducibility of Multiparametric MRICompletedNCT03743272
• A Post-Authorisation Non-Interventional Observational of Patients in France With Primary Biliary Cholangitis Treated With Obeticholic Acid in Real LifeStatus unknownNCT03703076
• Mindfulness - Based Intervention in the Treatment of Fatigue in Patients With Primary Biliary CholangitisTerminatedNCT03684187Not applicable
• Mesenchymal Stem Cell Transplantation for Refractory Primary Biliary CholangitisStatus unknownNCT03668145Not applicable
• Clinical Trial on the Effect of the Sublimated Mare Milk Supplement on Primary Biliary CholangitisCompletedNCT03665519Not applicable
• Trial of Psychoeducational and Hypnosis Interventions on the Fatigue Associated With PBC in WomenCompletedNCT03630718Not applicable
• Gut Microbes and Metabolic Group in Different PBC Patients for UDCA ResponseCompletedNCT03590886
• Probiotics in PBC Patients of Poor Response to UDCAStatus unknownNCT03521297Phase 2
• Development of Ursodeoxycholic Acid 300 mg at Hospital Das Clinicas of the University of São Paulo School of MedicineCompletedNCT03489889Not applicable
• Non-comparative Study of BCD-085 in Combination With UDCA in Patients With Primary Biliary CholangitisTerminatedNCT03476993Phase 2
• Autologous Bone Marrow Mononuclear Stem Cell for Children Suffering From Liver Cirrhosis Due to Biliary AtresiaCompletedNCT03468699Phase 2
• A Trial of 18-22mg/kg/d Ursodeoxycholic in Refractory Primary Biliary CholangitisStatus unknownNCT03345589Phase 4
• Paternally Inherited Phenotypes in CholestasisStatus unknownNCT03337074
• The Comparison About the Response of Ursodeoxycholic Acid in Primary Biliary Cholangitis Only and Primary Biliary Cholangitis With High Immune Globulin G or Aminotransferase at West China HospitalCompletedNCT03322943
• Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)Active, not recruitingNCT03301506Phase 3
• Effect of Obeticholic Acid on Transport of Bile Acids in PBC Examined by 11C-cholyl-sarcosine PET/CTCompletedNCT03253276Early Phase 1
• Performance of Scoring Systems in Chinese Patients With Primary Biliary Cholangitis (PBC) on Ursodeoxycholic AcidCompletedNCT03188146
• Study of E6011 in Japanese Subjects With Primary Biliary Cholangitis Inadequately Responding to Ursodeoxycholic AcidTerminatedNCT03092765Phase 2
• An Open Label, Single-dose, Single Period ADME Study of A4250 in Healthy SubjectsCompletedNCT03082937Phase 1
• Efficacy and Safety of Fenofibrate Combined With UDCA in PBC Patients With an Incomplete Biochemical Response to UDCAWithdrawnNCT02965911Phase 1/2
• A Safety and Pharmakokinetic Study of A4250 Alone or in Combination With A3384CompletedNCT02963077Phase 1
• Use of Bezafibrate in Patients With Primary Biliary Cirrhosis to Archive Complete Biochemical Response in Non-respondersStatus unknownNCT02937012Phase 3
• Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap SyndromeStatus unknownNCT02936596Not applicable
• A 5-year Longitudinal Observational Study of Patients With Primary Biliary CholangitisCompletedNCT02932449
• sCD163 in PBC Patients - Assessment of Disease Severity and PrognosisActive, not recruitingNCT02924701
• Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China HospitalCompletedNCT02917408
• Fuzhenghuayu for Patients With PBC Who Had An Inadequate Response to Ursodeoxycholic AcidStatus unknownNCT02916641Phase 3
• Fuzhenghuayu in Combination With Ursodeoxycholic Acid in Primary Biliary CirrhosisStatus unknownNCT02916290Phase 3
• The Health Burden of Primary Biliary Cirrhosis (PBC) in SwitzerlandCompletedNCT02846896
• Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic AcidStatus unknownNCT02823366Phase 3
• Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary CirrhosisCompletedNCT02823353Phase 3
• The Effect of Bezafibrate on Cholestatic ItchStatus unknownNCT02701166Phase 3
• Nalfurafine Hydrochloride for Pruritus in Patients With Primary Biliary CholangitisCompletedNCT02659696
• Effectiveness of S-adenosyl-L-methionine in Patients With Primary Biliary CirrhosisCompletedNCT02557360Phase 4
• Identification of Inflammatory and Fibrotic Biomarkers in PBC and NAFLD PatientsCompletedNCT02477462
• B-Cell Depleting Therapy (Rituximab) as a Treatment for Fatigue in Primary Biliary CirrhosisCompletedNCT02376335Phase 2
• IBAT Inhibitor A4250 for Cholestatic PruritusTerminatedNCT02360852Phase 2
• An Open-label Study to Evaluate the Long-term Safety and Tolerability of LUM001 in Patients With Primary Biliary CirrhosisWithdrawnNCT02321306Phase 2
• Pilot Study of FFP104 Dose Escalation in PBC SubjectsStatus unknownNCT02193360Phase 1/2
• Phase 2b Study of NGM282 Extended Treatment in Patients With Primary Biliary CirrhosisCompletedNCT02135536Phase 2
• Phase 2 Study of NGM282 in Patients With Primary Biliary CirrhosisCompletedNCT02026401Phase 2
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of PruritusCompletedNCT01899703Phase 2
• Safety and Efficacy of Tauroursodeoxycholic Acid Versus Ursofalk in the Treatment of Adult Primary Biliary CirrhosisCompletedNCT01857284Phase 3
• Umbilical Cord Mesenchymal Stem Cells for Patients With Primary Biliary CirrhosisStatus unknownNCT01662973Phase 1/2
• Phase 3 Study of Bezafibrate in Combination With Ursodeoxycholic Acid in Primary Biliary CirrhosisCompletedNCT01654731Phase 3
• Highly Active Antiretroviral Therapy for Patients With Primary Biliary CirrhosisTerminatedNCT01614405Not applicable
• High-protein High-fiber Diet in Patients With Primary Biliary CirrhosisCompletedNCT01603199Not applicable
• Ursofalk Tablets (500 mg) Versus Ursofalk Capsules (250 mg) in the Treatment of Primary Biliary CirrhosisCompletedNCT01510860Phase 4
• Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary CirrhosisStatus unknownNCT01440309Phase 1
• Primary Biliary Cirrhosis: Investigating A New Treatment Option Using NI-0801, an Anti-CXCL10 Monoclonal AntibodyTerminatedNCT01430429Phase 2
• Genetic Epidemiology of Primary Biliary Cirrhosis (PBC)CompletedNCT01161953
• Fenofibrate in Combination With Ursodeoxycholic Acid (UDCA) in Primary Biliary CirrhosisWithdrawnNCT01141296Phase 2
• Modafinil in the Treatment of Fatigue in Patients With Primary Biliary Cirrhosis (PBC)CompletedNCT00943176Phase 1
• Safety and Efficacy of Long-Term Treatment With Atorvastatin in Patients With Primary Biliary CirrhosisCompletedNCT00844402Phase 3
• Study Comparing Tetrathiomolybdate vs Standard Treatment in Primary Biliary CirrhosisCompletedNCT00805805Phase 3
• Ursodeoxycholic Acid Plus Budesonide Versus Ursodeoxycholic Acid Alone in Primary Biliary Cirrhosis (PBC)TerminatedNCT00746486Phase 3
• Moexipril for Primary Biliary CirrhosisCompletedNCT00588302Phase 2
• Oral Budesonide in the Treatment of Patients With Primary Biliary Cirrhosis and Overlap Features of Autoimmune HepatitisWithdrawnNCT00587119Not applicable
• Study of Combivir for Patients With Primary Biliary CirrhosisCompletedNCT00490620Phase 2/3
• Pharmacokinetic Study Of Tigecycline In Adult Subjects With Primary Biliary CirrhosisCompletedNCT00406237Phase 1
• Stem Cell Transplantation in Patients With Primary Biliary CirrhosisWithdrawnNCT00393185Phase 1

← Liver Cirrhosis, Biliary overview